特里普托利德通过ER压力和氧化还原调节诱导子宫癌细胞的免疫细胞死亡
Ziwen Zheng1,2, Yamei Chen2, Chao Wang2
1The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang 330006, Jiangxi, China.
American journal of cancer research
|February 14, 2025
概括
三胺 (TL) 通过诱导免疫细胞死亡 (ICD) 来表现出强大的抗癌作用,对宫癌产生强烈的抗癌作用. 这种天然化合物有效地抑制瘤生长,可能为宫癌治疗提供一种新的免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫癌是一个重大的全球卫生挑战,特别是在发展中国家.
- 现有的晚期或转移性子宫癌的治疗方法需要新的治疗策略.
- 来自Tripterygium wilfordii的三胺 (TL) 显示出广泛的抗癌特性.
研究的目的:
- 为了研究Triptolide (TL) 对宫癌细胞的抗癌作用.
- 探索TL的作用机制,专注于诱导免疫细胞死亡 (ICD).
- 在临床前宫癌模型中评估TL的疗效和安全性.
主要方法:
- 在体外测试评估细胞毒性,增殖和亡.
- 对ICD标记物的分析:卡莱蒂库林 (CRT) 暴露,HMGB1和ATP释放.
- 在体内研究使用宫癌异种移植模型与口服TL的管理.
- 调查内等质网膜 (ER) 应激和免疫通路激活.
主要成果:
- 在宫癌细胞中,TL表现出显著的细胞毒性,抑制了增殖,并诱导了细胞亡.
- 通过ER应激,TL成功诱导了免疫细胞死亡 (ICD),CRT暴露和HMGB1/ATP释放证明了这一点.
- 口服TL显著抑制了体内瘤生长,没有显著的毒性.
- TL治疗激活了氧化应激和与免疫相关的途径.
结论:
- ptolide (TL) 通过诱导免疫细胞死亡 (ICD) 对宫癌表现出强烈的抗癌活性.
- TL显示出作为治疗宫癌的新型免疫治疗剂的潜力,需要进一步的临床研究.
- 用TL和免疫检查点抑制剂进行组合治疗可能会提高治疗疗效,并最大限度地减少不良影响.
相关概念视频
The Extrinsic Apoptotic Pathway
6.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.0K
The Intrinsic Apoptotic Pathway
6.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Overview of Cell Death
6.5K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
6.5K
Cytotoxic T Cells-mediated Immune Response
830
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
830
Electron Transport Chain: Complex I and II
10.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.3K
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463


